Short answer · Medically reviewed summary · Last updated: 2026-04-07
Prader-Willi Syndrome is most commonly referred to by its eponymous name, though it is historically known as Labhart-Willi-Prader-Fanconi syndrome or Prader-Labhart-Willi syndrome. While medical literature and international classification systems now standardize the term as Prader-Willi Syndrome, patients may encounter older terminology in legacy medical records or European clinical reports. Why does Prader-Willi Syndrome have multiple names? The naming of Prader-Willi Syndrome reflects the history of medical discovery in the mid-20th century.
Prader-Willi Syndrome is most commonly referred to by its eponymous name, though it is historically known as Labhart-Willi-Prader-Fanconi syndrome or Prader-Labhart-Willi syndrome. While medical literature and international classification systems now standardize the term as Prader-Willi Syndrome, patients may encounter older terminology in legacy medical records or European clinical reports.
The naming of Prader-Willi Syndrome reflects the history of medical discovery in the mid-20th century. The condition was first described in detail in 1956 by Swiss physicians Andrea Prader, Alexis Labhart, and Heinrich Willi. Early medical literature often attributed the syndrome to all three researchers, leading to the name Prader-Labhart-Willi syndrome. Over time, the medical community shortened the designation to Prader-Willi Syndrome for clinical efficiency. Because Prader-Willi Syndrome is a complex multisystem disorder, some older texts may also refer to it by its primary clinical features, such as "hypotonia-hypomentia-hypogonadism-obesity syndrome," though this descriptive terminology is now largely obsolete.
To ensure consistency in global healthcare, Prader-Willi Syndrome is cataloged under specific international codes. These codes help clinicians, researchers, and insurance providers identify the condition accurately regardless of the synonym used:
In modern clinical practice, Prader-Willi Syndrome is the universally accepted and preferred term. Using this specific name is essential when communicating with specialists, as it ensures that your healthcare team is accessing the most current research and diagnostic protocols. Currently, 241 people within the DiseaseMaps.org community identify with this diagnosis, and utilizing the standard name helps in connecting with peers and finding resources specific to the condition. Avoid using older, descriptive names in current medical correspondence, as these may lead to confusion in electronic health record systems.
While Prader-Willi Syndrome is the primary name used globally, you may occasionally see regional variations in historical European medical journals. For example, some French or German texts from the 1960s and 1970s may still use "Syndrome de Prader-Labhart-Willi." Despite these variations, the underlying genetic cause—typically a deficiency in the expression of genes on the paternal chromosome 15 (15q11.2-q13)—remains the defining feature that unites these naming conventions under one clinical umbrella.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.